Contineum Therapeutics, Inc.
CTNM
$11.01
$0.575.46%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 182.41M | 175.48M | 190.71M | 204.76M | 213.91M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.52M | 1.36M | 1.42M | 1.63M | 1.23M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 184.93M | 176.84M | 192.13M | 206.39M | 215.14M |
|
|
|||||
| Total Current Assets | 184.93M | 176.84M | 192.13M | 206.39M | 215.14M |
| Net Property, Plant & Equipment | 5.65M | 5.86M | 6.13M | 6.46M | 888.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 266.00K | 186.00K | 4.00K | 3.00K | 3.00K |
| Total Assets | 190.85M | 182.89M | 198.26M | 212.85M | 216.03M |
|
|
|||||
| Total Accounts Payable | 786.00K | 2.00M | 3.65M | 1.81M | 1.40M |
| Total Accrued Expenses | 4.10M | 3.75M | 3.85M | 6.71M | 3.80M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.48M | 1.47M | 1.46M | 1.45M | 611.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 6.36M | 7.21M | 8.95M | 9.97M | 5.81M |
|
|
|||||
| Total Current Liabilities | 6.36M | 7.21M | 8.95M | 9.97M | 5.81M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 4.02M | 4.28M | 4.55M | 4.81M | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 10.38M | 11.50M | 13.50M | 14.78M | 5.81M |
|
|
|||||
| Common Stock & APIC | 342.43M | 320.68M | 317.99M | 315.40M | 312.50M |
| Retained Earnings | -162.22M | -149.43M | -133.39M | -117.40M | -102.84M |
| Treasury Stock & Other | 265.00K | 147.00K | 170.00K | 71.00K | 561.00K |
| Total Common Equity | 180.47M | 171.39M | 184.77M | 198.07M | 210.23M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 180.47M | 171.39M | 184.77M | 198.07M | 210.23M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 180.47M | 171.39M | 184.77M | 198.07M | 210.23M |
|
|
|||||